Hikal signs long term supply pact with leading global Biopharma Company

02 Jul 2013 Evaluate

Hikal, the preferred long-term outsourcing partner for leading global life sciences companies, has signed a long term pharmaceutical supply contract with a global biopharmaceutical company. The agreement covers the production and supply from the company’s pharmaceutical division. The customer is a leading innovator company which serves markets globally for human health treatments.

Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.